RSS  JOBS   SITE MAP 
 HOME 
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
 RESOURCE CENTER 
 NEWSLETTER 
 DIGITAL MAGAZINE 
  Friday, February 10, 2012 SEARCH     
 
 
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement

 
Pharma  Policies  Story
FDA warns consumers to avoid TimeOut capsules

Singapore, Aug 26, 2010: The US Food and Drug Administration (FDA) is warning consumers not to take TimeOut capsules, because it contains an active drug ingredient that can dangerously lower blood pressure. The product is marketed as a dietary supplement for sexual enhancement.

TimeOut is labeled as '100 percent natural', and consumers may mistakenly assume the product is harmless and poses no health risk. TimeOut is distributed on internet sites and online marketplaces as 2,500 mg capsules.

According to the FDA, consumers who take TimeOut capsules should stop using them immediately. Sexual enhancement products that claim to work as well as prescription products are likely to expose consumers to unpredictable risks and the potential for injury or death.

The FDA analyzed TimeOut and determined that it contains hydroxythiohomosildenafil, a chemical similar to sildenafil, the active ingredient in Viagra. Like sildenafil, this chemical may interact with prescription drugs such as nitrates, including nitroglycerin, and cause dangerously low blood pressure. When blood pressure drops suddenly, the brain is deprived of an adequate blood supply which can lead to dizziness or light-headedness.

To date, the FDA is not aware of any adverse events associated with the use of this product. The FDA advises consumers who have experienced any negative side-effects from sexual enhancement products, to consult a healthcare professional and to safely discard the product.

During the past several years, the FDA has found many products marketed as dietary supplements for sexual enhancement that can be harmful to consumers, because they are adulterated with ingredients in FDA-approved drugs or variations of these ingredients.


© BioSpectrum Bureau
  Email this articleComment on this article   Print this article
 
Advertisement











 
   
 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Jobs at CyberMedia | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[DQ Channels]  [The DQweek]  [DARE]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black